HK1025999A1 - Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides. - Google Patents

Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides.

Info

Publication number
HK1025999A1
HK1025999A1 HK00105273A HK00105273A HK1025999A1 HK 1025999 A1 HK1025999 A1 HK 1025999A1 HK 00105273 A HK00105273 A HK 00105273A HK 00105273 A HK00105273 A HK 00105273A HK 1025999 A1 HK1025999 A1 HK 1025999A1
Authority
HK
Hong Kong
Prior art keywords
virus
protein
peptides
dengue
epitopes
Prior art date
Application number
HK00105273A
Other languages
English (en)
Inventor
Susana Vazquez Ramudo
Guadalupe Guzman Tirado
Gerardo Enrique Guillen Nieto
Orlando Luis Pardo Lazo
Glay Chinea Santiago
Ana Beatriz Perez Diaz
Maritza Pupo Antunez
Rosmari Rodriguez Roche
Osvaldo Reyes Acosta
Hilda Elisa Garay Perez
Gabriel Padron Palomares
Maylin Alvarez Vera
Luis Morier Diaz
Omaida Perez Insuita
Pelegrino Martinez De La Luis
Original Assignee
Ct Ingenieria Genetica Biotech
Inst De Medicina Tropical Pedr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech, Inst De Medicina Tropical Pedr filed Critical Ct Ingenieria Genetica Biotech
Publication of HK1025999A1 publication Critical patent/HK1025999A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24111Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/18Togaviridae; Flaviviridae
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK00105273A 1997-01-15 2000-08-22 Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides. HK1025999A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU1997013A CU22683A1 (es) 1997-01-15 1997-01-15 Epítopes de la proteína pre-m/m del virus del dengue, péptidos sintéticos, proteínas quiméricas y sus usos
PCT/CU1998/000001 WO1998031814A1 (es) 1997-01-15 1998-01-13 Epitopes de la proteina pre-m/m del virus del dengue, peptidos sinteticos

Publications (1)

Publication Number Publication Date
HK1025999A1 true HK1025999A1 (en) 2000-12-01

Family

ID=5459193

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00105273A HK1025999A1 (en) 1997-01-15 2000-08-22 Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides.

Country Status (15)

Country Link
US (1) US6383488B1 (pt)
EP (1) EP0966535B1 (pt)
JP (1) JP3647048B2 (pt)
CN (1) CN1198933C (pt)
AT (1) ATE284444T1 (pt)
AU (1) AU743414B2 (pt)
BR (1) BR9807486A (pt)
CA (1) CA2277816A1 (pt)
CU (1) CU22683A1 (pt)
DE (1) DE69828032T2 (pt)
ES (1) ES2235310T3 (pt)
HK (1) HK1025999A1 (pt)
MY (1) MY120971A (pt)
NO (1) NO993468L (pt)
WO (1) WO1998031814A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23245A1 (es) * 2001-07-16 2007-10-17 Inst De Medicina Tropical Pedr CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS
CN101397574A (zh) * 2001-12-04 2009-04-01 巴法里安诺迪克有限公司 黄病毒ns1亚单位疫苗
EP1454988A1 (en) * 2003-03-03 2004-09-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Infectious flavivirus pseudo-particles containing functional prM-E envelope proteins
US7281274B2 (en) * 2003-10-16 2007-10-09 Lmp Media Llc Electronic media distribution system
CA2576798C (en) * 2004-07-27 2014-09-09 Gwong-Jen J. Chang Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use
CU23578A1 (es) 2005-09-16 2010-09-30 Ct Ingenieria Genetica Biotech Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal
CU23630A1 (es) 2006-10-30 2011-02-24 Ct Ingenieria Genetica Biotech Moléculas peptídicas quiméricas con propiedades antivirales contra los virus de la familia flaviviridae
WO2009024534A2 (en) * 2007-08-17 2009-02-26 Intercell Ag Japanese encephalitis virus (jev) and tick-borne encephalitis virus (tbev) peptides stimulating human t cell responses
CU20080028A6 (es) * 2008-02-29 2011-02-24 Ct Ingenieria Genetica Biotech Compuestos químicos obtenidos in silico para la preparación de composiciones farmacéuticas para atenuar o inhibir la infección por virus dengue y otros flavivirus
BRPI0914012B1 (pt) * 2008-10-13 2022-02-15 Institute For Research In Biomedicine Composição farmacêutica e uso da composição farmacêutica
CN101921310B (zh) * 2009-06-15 2014-03-12 温州医学院 登革病毒特异性hla-a2限制性表位肽及应用
WO2011133112A1 (en) * 2010-04-20 2011-10-27 National University Of Singapore Cell penetrating peptide derived from the premembrane protein of flavivirus
BR112013030637A2 (pt) * 2011-05-26 2018-06-12 Inst De Medicina Molecular peptídeo derivado do vírus da dengue (denv) e métodos para a inibição da replicação de flavivírus
CU24188B1 (es) * 2012-12-27 2016-07-29 Ct De Ingeniería Genética Y Biotecnología Composición vacunal contra el virus dengue
MX365957B (es) * 2013-06-26 2019-06-20 Univ North Carolina Chapel Hill Métodos y composiciones para vacunas del virus del dengue.
TWI769185B (zh) * 2016-10-27 2022-07-01 海樂源有限公司 登革熱類病毒顆粒、抗登革熱病毒抗體、及含其之組合物
CN116082499B (zh) * 2021-11-08 2023-10-27 东莞市朋志生物科技有限公司 一种抗登革ns1蛋白的抗体及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6093296A (en) * 1995-06-07 1996-12-30 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Infectious dengue 2 virus pdk-53 as quadravalent vaccine

Also Published As

Publication number Publication date
ES2235310T3 (es) 2005-07-01
NO993468D0 (no) 1999-07-14
CN1198933C (zh) 2005-04-27
NO993468L (no) 1999-09-14
AU5649998A (en) 1998-08-07
EP0966535A1 (en) 1999-12-29
ATE284444T1 (de) 2004-12-15
CN1249781A (zh) 2000-04-05
JP2001508457A (ja) 2001-06-26
JP3647048B2 (ja) 2005-05-11
BR9807486A (pt) 2000-03-21
AU743414B2 (en) 2002-01-24
CU22683A1 (es) 2001-07-20
DE69828032T2 (de) 2005-12-01
MY120971A (en) 2005-12-30
WO1998031814A1 (es) 1998-07-23
CA2277816A1 (en) 1998-07-23
US6383488B1 (en) 2002-05-07
DE69828032D1 (de) 2005-01-13
EP0966535B1 (en) 2004-12-08

Similar Documents

Publication Publication Date Title
HK1025999A1 (en) Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides.
Berasain et al. Fasciola hepatica: parasite-secreted proteinases degrade all human IgG subclasses: determination of the specific cleavage sites and identification of the immunoglobulin fragments produced
CA2623329A1 (en) Chimeric antigen containing hepatitis c virus polypeptide and fc fragment for eliciting an immune response
AU776844B2 (en) Early detection of flaviviruses using the NS1 glycoprotein
Costa et al. DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice
ECSP064643A (es) Proteinas de fusion de glp-1
HUP0202796A2 (en) Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
DE112006000677A5 (de) Rekombinante Expression von Proteinen in einer disulfidverbrückten, zweikettigen Form
DK1278534T3 (da) Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1
Sun et al. Identification of two linear B-cell epitopes from West Nile virus NS1 by screening a phage-displayed random peptide library
CN109182380A (zh) 杆状病毒表达的猪瘟e2亚单位疫苗的制备方法及应用
ATE382696T1 (de) Immunoreaktive antigene des hepatitis e viruses
DE69928064D1 (de) Mimotopen der hypervariabele region des e2 glykoproteins von hcv und deren verwendungen
ATE357526T1 (de) Modifizierte hcv peptid-impfstoffe
WO1999048908A3 (fr) POLYPEPTIDE IMMUNOREACTIF DU RECEPTEUR TrkA du NGF ET UTILISATIONS
AU9629498A (en) Method for the production of (poly)peptides by using truncated variants of the sv40 large t antigen with an intact n terminus
Takahashi et al. Effects of the number of amino acid residues in the signal segment upstream or downstream of the NS2B-3 cleavage site on production and secretion of prM/ME virus-like particles of West Nile virus
Dueñas‐Carrera et al. Immunological evaluation of Escherichia coli‐derived hepatitis C virus second envelope protein (E2) variants
WO2002051237A3 (en) Helicobacter proteins, nucleic acids and uses thereof
TH35001A (th) เอพิโทป pre-m/m ของ dengue virus, เปปไทด์สังเคราะห์ ไคเมอริกโปรตีนและการใช้สิ่งที่กล่าว
WO2004056316A3 (en) Vaccines against hiv-1 tat protein to generate neutralizing antibodies
Martínez et al. Humoral immune response against a hepatitis C Virus Envelope E2 variant expressed in Escherichia coli
RU2221873C2 (ru) Способ получения каталитических антител (варианты), антигены для иммунизации и нуклеотидная последовательность
Borras-Cuesta et al. Immunogenicity of synthetic peptides corresponding to regions of the major inner capsid protein of bovine rotavirus (BRV)
EP1310512A3 (en) Hcv core protein sequences

Legal Events

Date Code Title Description
AM Amended specification (according sect 146 of patent law)

Free format text: CORRECTION OF THE CHINESE NAMES OF INVENTORS

Effective date: 20050929

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090113